Company solutions for ecology and economy. Politics, technologies, innovations, clean energy, home and work, DIY and self-construction, repairing a breakdown, health, bitcoins and alternative finance
I was talking about the hopes of the documentary. I have enough km on the odometer to have read and heard this kind of speech which leads to some cases highlighted and silence on the failures or dangers which result from these attempts. Remember the billions of dollars invested in cancer research and for a deplorable, if not zero, result (considering the number is not decreasing) or for the papillomavirus, the same goes for vaccinations which are not only a major failure, but in addition were used to develop auto immune diseases, much more worrying, and of course the same for the famous HIV which also generates billions of dollars in the juicy pharmacy markets.Janic, the fantasies of the present are often the reality of the future!
No, no mention of the jellyfish!In the same genre there is also the immortal jellyfish: Science-and-Technology / jellyfish-a-immortal-yet-more-strong-as-the-tardigrade-t12494.html
(maybe they talked about it in the doc you cite?)
the real question is rather: is there conspiracy or not? In general, it is the minorities that are considered conspiratorial and not the other way around: why? A truth would automatically be on the side of the greatest number! In this case ecology would be a conspiracy lobbie (as some do not hesitate to say) when it criticizes this world of pollution!christophe wrote:Do not get into conspiracy lobbyism too quickly it becomes heavy janic there ...
EXCLUSIVE. A new step towards immortality ?
The French biotechnology company Cellectis announced Monday a world first: the possibility of "making a genetic backup to reset one day".
October 25, 2023. Los Angeles. On his favorite golf course, Edward, 59, a Hollywood star actor, is struck down by a heart attack. He may never get a normal life again. Fortunately, this enthusiast of innovation signed, ten years earlier, a contract with the company Scéil. Suddenly, his surgeon will be able to restore his coronary tissue, with heart cells containing Edward's own DNA. Zero risk of immune rejection ...
Science fiction? Partly only. Because the French biotechnology company Cellectis announces, this evening, a world first! Its CEO, André Choulika, is on tour this week in New York and Los Angeles to launch its new subsidiary Scéil, which offers this futuristic contract. A bold bet on the progress of pharmacy and medicine, which tomorrow, he says, will routinely develop personalized drugs and regenerative therapies.